Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
Manabu Inoue, Chief Medical Officer at Pharmaceuticals and Medical Devices Agency (PMDA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Neurology, adding:
”I am pleased to share that the T-FLAVOR trial has been published in JAMA Neurology.
T-FLAVOR is a multicenter, randomized clinical trial comparing tenecteplase with the approved Japanese low-dose alteplase (0.6 mg/kg) before endovascular thrombectomy in patients with acute ischemic stroke.
To our knowledge, this is the first randomized trial to evaluate these two thrombolytic strategies in Japan.
I am sincerely grateful to all investigators, study coordinators, patients, and their families for making this study possible.
I hope these findings will contribute to improving stroke care and advancing evidence-based treatment worldwide.”
Title: Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion. A Randomized Clinical Trial
Authors: Manabu Inoue, Teruyuki Hirano, Mayumi Fukuda-Doi, Hiroyuki Kawano, Kenta Tanaka, Nobuyuki Sakai, Masatoshi Koga, Koji Iwasaki, Tomohide Yoshie, Naruhiko Kamogawa, Masafumi Ihara, Tsuyoshi Ohta, Masaki Chin, Naoto Kimura, Kazumi Kimura, Yohei Tateishi, Tadashi Terasaki, Taketo Hatano, Takahiro Kuwashiro, Shinichi Yoshimura, Toshihiro Ueda, Eiichiro Nagata, Yoshinari Nagakane, Shinichi Takahashi, Fumio Miyashita, Kazutaka Sonoda, Kenji Fukuda, Kanta Tanaka, Yoshiko Une, Shigetaka Kobari, Takehiko Nagao, Makoto Sasaki, Haruko Yamamoto, Kazunori Toyoda for the T-FLAVOR trial Investigators

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 24, 2026, 05:04Moustafa Abdou: Unmasking Pure Red Cell Aplasia
-
Jul 24, 2026, 04:53Ana Pedrero Gil: The Future of Blood-Derived Therapies
-
Jul 24, 2026, 04:50Marc Wittwer: How We’re Making Hemostasis Diagnostics Faster, Simpler, and More Ergonomic
-
Jul 24, 2026, 04:41Akshat Jain: Reassessing Cost-Effectiveness of Iron Deficiency Anemia Treatments
-
Jul 24, 2026, 04:36Mehari Gebreyohanns: The Official Event Page for ASOC 2026 Is Now Live
-
Jul 24, 2026, 03:57Balvinder Bobbie Saarsalu: Hemostatic Biomarkers in Acute Myeloid Leukemia
-
Jul 24, 2026, 03:49Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
-
Jul 24, 2026, 03:36We Received The AHA Get With The Guidelines Stroke Gold Plus Quality Achievement Award – Lakeland Regional Health-Florida
-
Jul 24, 2026, 03:31Ana Catarina Fonseca: The Persistent Gaps in Blood Pressure Guideline Achievement After Stroke